Tag Archives: vaccine

Chemotherapy for Mesothelioma May Work Better with TroVax

vaccine added to chemotherapy for mesothelioma

UK researchers say a cancer vaccine called Trovax has the potential to boost the power of chemotherapy for mesothelioma. Chemotherapy is the main treatment for malignant pleural mesothelioma. Mesothelioma is a cancer of the lung lining caused by asbestos exposure. It is very hard to treat. Even people who have chemotherapy for mesothelioma do not usually live more than two years after diagnosis. Mesothelioma researchers are always looking for ways to improve chemotherapy for mesothelioma. It is often combined with other treatments like surgery, radiation or immunotherapy. Now, scientists think adding TroVax to mesothelioma chemotherapy may be another good option. What is the TroVax Cancer Vaccine? The TroVax cancer vaccine is made by UK-based Oxford BioMedica. It contains an altered … Continue reading Chemotherapy for Mesothelioma May Work Better with TroVax »

Promising Early Results from Mesothelioma Vaccine Trial

Researchers studying a new immunotherapy vaccine for mesothelioma have released early findings from an ongoing clinical trial and the results are promising. CRS-207 is based on a genetically modified version of Listeria monocytogenes, a bacterium normally associated with the food borne illness, Listeriosis. The drug was designed to induce a powerful immune response against cells that produce mesothelin, which includes mesothelioma and several other kinds of cancer. In a presentation at the 40th European Society for Medical Oncology in September, lead investigator Raffit Hassan, MD, of the National Cancer Institute said CRS-207 appears to be improving the odds of surviving mesothelioma in inoperable patients. “The data in this trial continue to be impressive in the front-line treatment of mesothelioma,” said … Continue reading Promising Early Results from Mesothelioma Vaccine Trial »

Immune-Stimulating Vaccine “Cures” Mesothelioma in Mice

Researchers from Hong Kong claim to have found a way eradicate mesothelioma in mice using a DNA vaccine. Microbiologists at the University of Hong Kong have even gone so far as to use the word “cure” in their recently-published paper in the journal Cancer Research. Like other types of cancer, asbestos-induced mesothelioma spreads, in part, by suppressing the body’s natural anti-cancer defenses. The Hong Kong team administered a vaccine based on PD-1, a protein known as “programmed cell death protein 1”, to effectively reprogram the DNA of the lab mice, turning those natural defenses back on. According to the report, the PD-1-based DNA vaccine conferred “complete and long-lasting protection” against “lethal mesothelioma challenge” in the mice. But the advantages did … Continue reading Immune-Stimulating Vaccine “Cures” Mesothelioma in Mice »